Welcome to Spinwatch
Nuclear Spin


          Content
Home Home
About SpinWatch About SpinWatch
 Articles By Category Articles By Category
Latest News Latest News
 News By Category News By Category
Blogs Blogs
Reviews Reviews

          Newsletter
Stay informed with the Spinwatch newsletter.


          Information
Book Shop Book Shop
Nuclear Spin Nuclear Spin
 Events Calendar
News Feeds News Feeds
Video Video
Links Links
Feedback Feedback
Donations Donations
Whistleblowers Whistleblowers


         Whistleblower
Are You Disillusioned with the PR tactics of your employer?

Or have you got a story on the PR industry?

Call the spinbusting hotline:
+44 (0)7939 529 349

or Email: whistleblower

         Saro Wiwa

         Technorati Authority
View blog authority

Drug firms eavesdrop on patients chatroom gossip PDF Print E-mail
The Times

By Nigel Hawkes, Health Editor

A LEADING drug company is covertly listening in to thousands of conversations on the internet to discover what patients think of its products. Every day patients or carers log on to newsgroups, chatrooms and forums to exchange information. Health is one of the most important subjects of internet traffic, third only to computers and holidays.

Potentially, the opinions exchanged are of great value to manufacturers of all kinds of products, not just the drug companies. They can provide early warning of problems, such as side-effects in the case of drugs, and enable companies to correct faults before they damage sales. Just as valuably, they contain lots of information about rival products.

This is made possible by a new web tool called iReputation, which has been developed by the online brand marketing company NetRank. The system monitors the internet for keywords ? such as the name of a drug ? trawling every relevant site every few minutes.

It picks up a large range of opinions, sorting them into a trend graph. From time to time the graph shows sharp peaks as a new issue appears, which alerts brand-owners. Generally companies that use the system, including the mobile phone manufacturer Motorola, employ a person to sift the data.

John Straw, chief executive officer of NetRank, said that there were at least 5,000 postings a day to health newsgroups and 10,000 to forums. ?We can pick up every single reference to a drug name, then display the results graphically. But it?s up to the human manager to make judgments.?

He declined to say which of the main drug companies had subscribed to the service, which costs ?1,000 a month for each brand name. The tool could be especially valuable in Britain and other EU countries where laws prevent drug companies from making direct contact with patients.

Mr Straw believes that the system has something to offer drug regulatory agencies in post-marketing surveillance. At present, side-effects of drugs are recorded on Yellow Cards filled in by doctors and sent to the Medicines and Healthcare Products Regulatory Agency. But the system picks up problems only when patients report them to their GPs.
 
< Prev   Next >
Upcoming Events

          Latest News
More News

          Latest Reviews
          Latest Blogs
 

Designed and Maintained By SCS Web Design
Website Enquiries Contact webmaster@spinwatch.org